Table 2.
Summary of clinical response.
| Patient number | Clinical outcome | Time to complete response (weeks) | Follow-up period (months) | Maximun dose received (mg) | Relapse | Dose at relapse |
|---|---|---|---|---|---|---|
| 1 | CR | 10 | 15 | 5 | Yes | 5 mg twice weekly |
| 2 | CR | 4 | 12 | 5 | Yes | 5 mg three times weekly |
| 3 | Withdrawn | - | - | 5 | - | - |
| 4 | CR | 3 | 12 | 5 | Yes | 5 mg alternate days |
| 5 | CR | 36 | 19 | 5 | - | - |
| 6 | CR | 4 | 17 | 5 | No | - |
| 7 | CR | 11 | 18 | 5 | No | - |
| 8 | CR | 2 | 7 | 5 | Yes | 5 mg alternate days |
| 9 | PR | - | 15 | 10 | - | - |
| 10 | CR | 7 | 10 | 5 | Yes | 5 mg alternate days |
| 11 | CR | 4 | 30 | 5 | Yes | 5 mg twice weekly |
| 12 | CR | 4 | 25 | 5 | Yes | 5 mg alternate days |
| 13 | PR | - | 8 | 5 | - | - |
| 14 | CR | 12 | 17 | 5 | Yes | 5 mg three times weekly |
| 15 | CR | 2 | 10 | 5 | Yes | 5 mg alternate days |
CR, complete response; PR, partial response.